Glassman Wealth Services Eli Lilly & CO Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $19,432 - $22,907	-37 Reduced 2.97%	1,207 $703,000
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $13,475 - $18,578	31 Added 2.56%	1,244 $668,000
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $24,201 - $32,359	69 Added 6.03%	1,213 $568,000
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $310 - $364	-1 Reduced 0.09%	1,144 $392,000
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $18,649 - $21,730	58 Added 5.34%	1,145 $418,000
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $14,527 - $16,555	49 Added 4.72%	1,087 $351,000
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $93,653 - $109,962	-336 Reduced 24.45%	1,038 $337,000
Q1 2022 Aug 23, 2022	BUY	$234.69 - $291.66 $9,856 - $12,249	42 Added 3.15%	1,374 $393,000
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $16,662 - $20,707	71 Added 5.63%	1,332 $381,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $24,508 - $30,415	109 Added 9.46%	1,261 $348,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $7,534 - $9,272	34 Added 3.04%	1,152 $266,000
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $11,735 - $15,180	65 Added 6.17%	1,118 $257,000
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $4,600 - $5,956	28 Added 2.73%	1,053 $197,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $4,957 - $6,559	38 Added 3.85%	1,025 $173,000
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $1,900 - $2,198	13 Added 1.33%	987 $146,000
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $682 - $820	-5 Reduced 0.51%	974 $160,000
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $9,047 - $11,198	76 Added 8.42%	979 $136,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $2,673 - $3,310	25 Added 2.85%	903 $119,000
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $13,989 - $15,216	-131 Reduced 12.98%	878 $98,000
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $5,207 - $6,078	47 Added 4.89%	1,009 $112,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $70,459 - $82,935	633 Added 192.4%	962 $125,000
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $35,881 - $41,181	-474 Reduced 59.03%	329 $28,000
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $35,843 - $42,310	483 Added 150.94%	803 $62,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $1,392 - $1,494	17 Added 5.61%	320 $27,000
Q2 2017 Aug 09, 2017	BUY	N/A	303	303 $25,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account